FDA Approves Manufacturing Plan For Menerba, Bionovo's Menopausal Hot Flash Drug Candidate

Bionovo, Inc. (Nasdaq: BNVI, BNVID) announced that the U.S. Food and Drug Administration (FDA) accepted the Company’s Chemistry, Manufacturing and Controls (CMC) plan for its lead drug candidate, Menerba®, in a Type “B” or “End of Phase 2″ meeting. With this designation, the decisions and agreements are now considered binding on the Company and the FDA…

FDA Approves Manufacturing Plan For Menerba, Bionovo's Menopausal Hot Flash Drug Candidate

Bionovo, Inc. (Nasdaq: BNVI, BNVID) announced that the U.S. Food and Drug Administration (FDA) accepted the Company’s Chemistry, Manufacturing and Controls (CMC) plan for its lead drug candidate, Menerba®, in a Type “B” or “End of Phase 2″ meeting. With this designation, the decisions and agreements are now considered binding on the Company and the FDA…

FDA Approves Manufacturing Plan For Menerba, Bionovo's Menopausal Hot Flash Drug Candidate

Bionovo, Inc. (Nasdaq: BNVI, BNVID) announced that the U.S. Food and Drug Administration (FDA) accepted the Company’s Chemistry, Manufacturing and Controls (CMC) plan for its lead drug candidate, Menerba®, in a Type “B” or “End of Phase 2″ meeting. With this designation, the decisions and agreements are now considered binding on the Company and the FDA…

Solution for a Calm and Comfortable Menopause

www.nutri5shop.info A Natural Solution for a Calm and Comfortable Menopause hot flushes, sweating, restlessness and irritability www.nutri5shop.info

FDA Approves Manufacturing Plan For Menerba, Bionovo's Menopausal Hot Flash Drug Candidate

Bionovo, Inc. (Nasdaq: BNVI, BNVID) announced that the U.S. Food and Drug Administration (FDA) accepted the Company’s Chemistry, Manufacturing and Controls (CMC) plan for its lead drug candidate, Menerba®, in a Type “B” or “End of Phase 2″ meeting. With this designation, the decisions and agreements are now considered binding on the Company and the FDA…

« Previous Page — Next Page »